Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

285 Press Releases
DateTitleCompany
25 Mar 14 Pfizer Invites Public To View And Listen To Webcast Of May 5 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
12 Mar 14 Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent Pfizer Inc.,
Published by
Business Wire
12 Mar 14 Pfizer Announces Webcast Of April 6 Conference Call With Securities Analysts To Review Palbociclib Phase 2 Final Results Following Presentation At AACR Annual Meeting 2014 Pfizer Inc.,
Published by
Business Wire
07 Mar 14 Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer’s Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone’s Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of Tikosyn® Capsules Pfizer Inc.,
Published by
Business Wire
23 Jan 14 Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study Pfizer Inc.,
Published by
Business Wire
21 Jan 14 CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly Pfizer Inc.,
Published by
Business Wire
17 Dec 13 Pfizer Settles Viagra® Patent Litigation With Teva Pfizer Inc.,
Published by
Business Wire
17 Dec 13 Pfizer Names Albert Bourla Group President; Vaccines, Oncology and Consumer Healthcare Business Pfizer Inc.,
Published by
Business Wire
17 Dec 13 Pfizer Invites Public To View And Listen To Webcast Of January 28 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
16 Dec 13 Pfizer Declares First-Quarter 2014 Dividend Pfizer Inc.,
Published by
Business Wire
04 Dec 13 Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal Pfizer Inc.,
Published by
Business Wire
02 Dec 13 Pfizer Acquires Polocard, Poland’s Leading Over-The-Counter Heart Attack Prevention Brand Pfizer Inc.,
Published by
Business Wire
25 Nov 13 Just in Time for Peak Travel Season, Introducing New Robitussin® DM Max Liquid-Filled Capsules Pfizer Inc.,
Published by
Business Wire
21 Nov 13 Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma Pfizer Inc.,
Published by
Business Wire
14 Nov 13 Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 Pfizer Inc.,
Published by
Business Wire
28 Oct 13 Howie Mandel Challenges People To Learn The Fibs And Facts About Atrial Fibrillation And Its Associated Increased Stroke Risk Pfizer Inc. and Bristol-Myers Squibb Company,
Published by
Business Wire
24 Oct 13 Pfizer Declares 24-Cent Fourth-Quarter 2013 Dividend Pfizer Inc.,
Published by
Business Wire
22 Oct 13 Pfizer Inc. Continues Development Program for Remoxy® (oxycodone) Extended-Release Capsules CII Pfizer Inc.,
Published by
Business Wire
18 Oct 13 Pfizer Reports Top-Line Results From Two Lyrica® Capsules CV Phase 3b Studies Pfizer Inc.,
Published by
Business Wire
09 Oct 13 ChapStick® Announces Olympic Gold Medalist Alex Morgan As New Face of the Brand Pfizer Inc.,
Published by
Business Wire
01 Oct 13 Pfizer Invites Public To View And Listen To Webcast Of October 29 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
30 Sep 13 Shantanu Narayen Elected To Pfizer's Board Of Directors Pfizer Inc.,
Published by
Business Wire
30 Sep 13 Advil® Becomes Official Pain Reliever of the National Hockey League and the 30 Team Athletic Trainers Pfizer Inc.,
Published by
Business Wire
26 Aug 13 Introducing New Advil® Film Coated Tablets – Designed to Stop Pain Before It Gets Worse Pfizer Inc.,
Published by
Business Wire
28 Jun 13 Pfizer Declares 24-Cent Third-Quarter 2013 Dividend Pfizer Inc.,
Published by
Business Wire
27 Jun 13 Pfizer Announces Final Results of Zoetis Exchange Offer Pfizer Inc.,
Published by
Business Wire
25 Jun 13 Pfizer Invites Public To View And Listen To Webcast Of July 30 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
12 Jun 13 Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix® Patent Pfizer Inc.,
Published by
Business Wire
29 May 13 Pfizer Prices $4.0 Billion Debt Offering Pfizer Inc.,
Published by
Business Wire
25 Apr 13 Top-Line Data Show Celecoxib Met Primary Objective In Clinical Trial To Evaluate The Effects On Blood Pressure In Pediatric Patients With Juvenile Idiopathic Arthritis Pfizer Inc.,
Published by
Business Wire
Advertising